Press Releases
Search
-
18 Mar 2021
BIOFIRE® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 obtains De Novo FDA Authorization
Marcy l’Étoile (France) – bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, its subsidiary specialized in molecular syndromic infectious diseas...
-
09 Mar 2021
The Biotech Digital Campus joins forces with biotechnology schools and training organizations to develop the talents of tomorrow
An unprecedented alliance serving the French bioproduction sector "Recipient of a Future Investment Program award" The Biotech Digital Campus is a recipient of the Engineering Action for innovative pr...
-
24 Feb 2021
bioMérieux – 2020 Financial Results
€3,118 million in full-year 2020 sales, up 19.7 % like-for-like Robust sales performance in the fourth quarter, with organic growth of 20.5 % led by sales of molecular biology reagents Contributive op...
-
03 Feb 2021
bioMérieux announces the CE marking of NEPHROCHECK® test on VIDAS®
Marcy l’Etoile, France – February 3rd , 2021 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced the CE marking of the innovative NEPHROCHECK® assay to detect kidney str...
-
16 Dec 2020
bioMérieux announces the CE marking of its molecular biology ARGENE® test for the simultaneous detection of SARS-CoV-2, influenza viruses A and B, and RSV and hMPV viruses
Marcy l’Etoile, France – December 16, 2020 – bioMérieux, a world leader in the field of in vitro diagnostics, has announced the expansion of its ARGENE® range for the real-time PCR (RT-PCR) detection ...
-
14 Dec 2020
Increased outlook for full-year 2020
Marcy l'Étoile, December 14, 2020 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its adjusted outlook for full-year 2020.